SpringerLink
Log in

Sollten Patienten nach überlebter akuter Nierenschädigung mit RAAS-Inhibitoren behandelt werden?

Should patients after surviving acute kidney injury be treated with RAAS inhibitors?

  • Für Sie gelesen
  • Published:
Der Nephrologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. James MT, Bhatt M, Pannu N, Tonelli M (2020) Long-term outcomes of acute kidney injury and strategies for improved care. Nat Rev Nephrol 16(4):193–205

    Article  Google Scholar 

  2. Ferrario CM, Mullick AE (2017) Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease. Pharmacol Res 125(Pt A):57–71

    Article  CAS  Google Scholar 

  3. Brar S, Ye F, James MT, Hemmelgarn B, Klarenbach S, Pannu N (2018) Interdisciplinary chronic disease collaboration. Association of Angiotensin-converting enzyme inhibitor or Angiotensin receptor blocker use with outcomes after acute kidney injury. JAMA Intern Med 178(12):1681–1690

    Article  Google Scholar 

  4. Hsu CY, Liu KD, Yang J, Glidden DV, Tan TC, Pravoverov L et al (2020) Renin-Angiotensin system blockade after acute kidney injury (AKI) and risk of recurrent AKI. Clin J Am Soc Nephrol 15(1):26–34

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik mit Schwerpunkt Nephrologie und Internistische Intensivmedizin, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Deutschland

    Laura Hoffmann &  Kai M. Schmidt-Ott

Authors
  1. Laura Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kai M. Schmidt-Ott
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Laura Hoffmann or Kai M. Schmidt-Ott.

Ethics declarations

Interessenkonflikt

L. Hoffmann und K.M. Schmidt-Ott geben an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

T. Feldkamp, Hann. Münden

J. Lutz, Koblenz

L.T. Weber, Köln

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hoffmann, L., Schmidt-Ott, K.M. Sollten Patienten nach überlebter akuter Nierenschädigung mit RAAS-Inhibitoren behandelt werden?. Nephrologe 16, 305–306 (2021). https://doi.org/10.1007/s11560-021-00514-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-021-00514-1

Search

Navigation